The Danish drugmaker prepares to introduce its once-a-week injectable, Ozempic, as India faces rising cases of Type 2 ...
On the occasion, Vishnu Saxena and Aditya Vyas highlighted how the collaboration will support HealthTech startups with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback